Sign in
4

Changes in Ownership

C4 Therapeutics, Inc. Filed Acc 0001662579-23-000008

Director acquired 712 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Anderson Kenneth Carl Director 2023-01-06 Option exercise +268 $2.11 $565 94,684 D
Anderson Kenneth Carl Director 2023-01-06 Option exercise +444 $4.98 $2,211 95,128 D
Derivatives
Anderson Kenneth Carl Director 2023-01-06 Option exercise · Stock Option (Right to Buy) −268 1,067 D
Anderson Kenneth Carl Director 2023-01-06 Option exercise · Stock Option (Right to Buy) −444 890 D
Loading xslF345X03/wf-form4_167304210044893.xml…